Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicentre,Open-label, Randomised Controlled, Non-inferiority Trial

NCT04797013 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT04797013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04797013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicentre,Open-label, Randomised Controlled, Non-inferiority Trial
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 3
Overall status
Completed
Start date
June 12, 2021
Completion date
July 15, 2022
Enrollment
1,430 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke